ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,849Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 1290

$890K Total Retail Price of All Prescriptions

Rank: 63 out of 1290

776 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 776 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 776 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 19,079 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 1,561 1,433 1 1
LISINOPRIL 950 872 2 5
OMEPRAZOLE 882 794 3 2
AMLODIPINE BESYLATE 625 551 4 3
LEVOTHYROXINE SODIUM 618 594 5 4
HYDROCHLOROTHIAZIDE 463 445 6 20
METFORMIN HCL 405 382 7 10
FENOFIBRATE 367 327 8 98
ALENDRONATE SODIUM 365 342 9 39
HYDROCODONE-ACETAMINOPHEN 346 316 S3 10 6
ALPRAZOLAM 345 330 11 47
METOPROLOL SUCCINATE 341 325 12 14
ZOLPIDEM TARTRATE 314 258 13 15
LOVASTATIN 304 298 14 45
LOSARTAN POTASSIUM 297 295 15 19
FUROSEMIDE 282 264 16 9
CARVEDILOL 265 254 17 12
CLOPIDOGREL 258 246 18 24
ATENOLOL 250 241 19 18
TAMSULOSIN HCL 245 244 20 11
PLAVIX 239 228 21 32
METOPROLOL TARTRATE 235 210 22 7
MELOXICAM 228 221 23 31
ATORVASTATIN CALCIUM 228 206 23 23
GABAPENTIN 217 184 25 8
BENAZEPRIL HCL 212 207 26 140
TEMAZEPAM 209 201 27 71
PANTOPRAZOLE SODIUM 200 186 28 48
ALLOPURINOL 196 186 29 60
DOXAZOSIN MESYLATE 195 195 30 64
DONEPEZIL HCL 194 179 31 13
CRESTOR 169 126 32 17
RANITIDINE HCL 168 162 33 49
GLYBURIDE-METFORMIN HCL 160 139 R 34 147
VIAGRA 156 142 35 124
ADVAIR DISKUS 155 138 36 37
METFORMIN HCL ER 149 148 37 135
GLIMEPIRIDE 145 142 38 57
FLUOXETINE HCL 144 144 39 79
WARFARIN SODIUM 142 134 40 22
SYNTHROID 137 137 41 28
VYTORIN 128 107 42 293
SERTRALINE HCL 126 117 43 36
MECLIZINE HCL 122 119 44 159
CLONIDINE HCL 114 95 45 66
FLUTICASONE PROPIONATE 113 99 46 26
ENALAPRIL MALEATE 111 102 47 62
LOSARTAN-HYDROCHLOROTHIAZIDE 109 103 48 106
PAROXETINE HCL 107 97 49 84
PROAIR HFA 106 92 50 73
PREDNISONE 104 95 51 21
DIGOXIN 103 91 52 51
NEXIUM 102 86 53 34
SPIRONOLACTONE 101 81 54 126
DIOVAN HCT 98 84 55 112
CITALOPRAM HBR 97 88 56 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 96 93 57 92
AZITHROMYCIN 90 81 58 61
PRAVASTATIN SODIUM 89 83 59 42
NAMENDA 87 87 60 27
TRAMADOL HCL 87 76 60 25
OXYBUTYNIN CHLORIDE ER 85 83 62 161
DIOVAN 81 78 63 53
TRIAMTERENE-HCTZ 79 75 64 130
TRAMADOL HCL-ACETAMINOPHEN 79 74 64 310
LORAZEPAM 74 72 66 132
POTASSIUM CHLORIDE 70 66 67 35
NAPROXEN 69 54 68 115
AMLODIPINE BESYLATE-BENAZEPRIL 68 65 69 166
RAMIPRIL 65 64 70 136
AMITRIPTYLINE HCL 64 64 R 71 97
PROPRANOLOL HCL 62 62 72 242
DICLOFENAC SODIUM 61 53 73 77
DILTIAZEM ER 59 57 74 262
LANTUS 58 52 75 67
CYMBALTA 58 46 75 59
CIPROFLOXACIN HCL 58 54 75 46
NIFEDIPINE ER 58 57 75 110
BENICAR HCT 56 56 79 241
BUPROPION XL 55 45 80 143
JANUVIA 54 54 81 82
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 45 82 137
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.